EGFR and breast carcinoma: In addition, 3-methylcholanthrene has been reported to activate EGFR/ERK/c-Fos transduction signaling through an Aryl hydrocarbon Receptor (AhR) and GPER-mediated mechanism in both breast cancer cells and Cancer-Associated Fibroblasts (CAFs).